Editorial Board for section 'Molecular Cancer Biology'
- Molecular Cancer Biology Section
- Cancer Immunology and Immunotherapy Section
- Cancer Biomarkers Section
- Cancer Epidemiology and Prevention Section
- Cancer Pathophysiology Section
- Tumor Microenvironment Section
- Cancer Causes, Screening and Diagnosis Section
- Cancer Survivorship and Quality of Life Section
- Cancer Therapy Section
- Clinical Research of Cancer Section
- Systematic Review or Meta-Analysis in Cancer Research Section
- Methods and Technologies Development Section
- Cancer Informatics and Big Data Section
- Pediatric Oncology Section
- Infectious Agents and Cancer Section
- Cancer Drug Development Section
- Cancer Metastasis Section
- Transplant Oncology Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Interests: genome wide epigenetic control of transcription; transcription factors and nuclear receptors; regulatory RNAs
Special Issues, Collections and Topics in MDPI journals
Interests: toxicology and molecular biology of estrogenic and antiestrogenic compounds; molecular mechanisms of estrogen receptor and Ah receptor action and their crosstalk in breast cancer; NR4A1 and Sp proteins as drug targets; long non-coding RNAs
Special Issues, Collections and Topics in MDPI journals
Section Board Member
Interests: cancer cell biology; EMT; signal transduction; TGF-beta; BMP
Interests: cancer metastasis; inflammation; molecular based cell signaling; advanced therapeutic approaches
Special Issues, Collections and Topics in MDPI journals
Interests: lung cancer; oncogenic drivers; MAPK signalling; mouse models
Interests: cancer progression; angiogenesis; redox homeostasis; metabolism; metastasi; oxidative stress; antioxidants
2. Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston, MA 02115, USA
3. Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA 02115, USA
Interests: apoptosis; cancer therapeutics; toxicity of cancer therapies; cell death
Interests: ovarian cancer; microRNA; exosomes; gynecology; gynecologic oncology; gynaecological surgery
Interests: pancreatic cancer; gastrointestinal cancer; clinical trials; predictive biomarkers; translational research; precision medicine
Special Issues, Collections and Topics in MDPI journals
Interests: NF-kB; inflammation; p53; DNA damage response
Interests: na
Interests: cancer stem cells; tumor microenvironment; angiogenesis; cancer biology; growth factors and cytokines; drug delivery systems; targeting cancer; liposomes; drug screening; self-organizing map
Special Issues, Collections and Topics in MDPI journals
Interests: molecular imaging; immunotherapy; cancers metabolism
Interests: HDAC; histone deacteylases; protein modifications; gene regulation
Interests: lung cancer; tumor pathology; base excision repair; centrosome regulation; gastric cancer
Interests: Janus kinase 2; cytokine signaling; JAK3 mutant
Interests: hypoxia; HIF-1; metabolism; phosphorylation; nuclear transport; cancer; apoptosis
Special Issues, Collections and Topics in MDPI journals
Interests: oxidative stress; nitric oxide; topoisomerases; pharmacology of anticancer drugs; mechanism of drug resistance
Special Issues, Collections and Topics in MDPI journals
Interests: bionanotechnology; epigenetics; eps/prostate cancer; MSP/QPCR/TaqMan (Rotor-Gene); DNA sizing (agilent); HPLC; DNA synthesizer; spectrophotometry (nanodrop); clinical trials
2. Department of Cell Biology, Physiology and Immunology, University of Cordoba, 14004 Córdoba, Spain
Interests: immunosenescence; NK cells; T and NK cell based immunotherapy; cytomegalovirus; leukemia
Special Issues, Collections and Topics in MDPI journals
Interests: epigenetics; HDAC inhibitor; molecular-targeting prevention
2. Department of Malignant Haematology and Stem Cell Transplantation, Clinical Haematology, 55 Commercial Road, Alfred Health, Melbourne 3004, Australia
Interests: haematology; biomarkers of drug responsiveness; blood cancer; clinical research; haematological malignancies; multiple myeloma; epigenetic therapies; novel therapeutics
Special Issues, Collections and Topics in MDPI journals
Interests: RNA-binding proteins in cancer; regulation of RNA turnover; melanoma; neuroblastoma; leukemia
2. Cancer Center at Illinois, University of Illinois, Urbana-Champaign, Urbana, IL 61801, USA
3. Institute of Genomic Biology, University of Illinois, Urbana-Champaign, Urbana, IL 61801, USA
Interests: testicular cancer; cancer therapeutics; chemoresistance; epigenetics; targeted therapy
Special Issues, Collections and Topics in MDPI journals
2. German Cancer Consortium (DKTK), Heidelberg, im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Interests: translational oncology; metastasis research, biomarker identification and analysis; cancer signaling; cancer therapy
Special Issues, Collections and Topics in MDPI journals
Interests: hippo tumor suppressor pathway; cancer chemoprevention; metformin; melatonin; natural anticancer agents; noncoding RNA factors
Interests: breast cancer; prostate cancer; cancer stem cells; hypoxia and cancer; cell signaling; chemotherapy resistance; therapy resistance
Special Issues, Collections and Topics in MDPI journals
Interests: prostate cancer; kidney cancer; lung cancer; genomic; epigenomic; transcriptomic; liquid biopsy
Interests: cell signaling; stem cells; angiogenesis; metastasis in breast cancer and hepatocellular carcinoma
Interests: lung cancer; molecular biology; molecular targeted therapy; immunotherapy
Special Issues, Collections and Topics in MDPI journals